We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

168 hedge funds and large institutions have $717M invested in Emergent Biosolutions in 2014 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 57 increasing their positions, 50 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 8

27% more funds holding

Funds holding: 132 → 168 (+36)

26% more capital invested

Capital invested by funds: $570M → $717M (+$148M)

14% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 50

9.04% more ownership

Funds ownership: 69.27% → 78.3% (+9%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
168
Holders Change
+36
Holders Change %
+27.27%
% of All Funds
4.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
44
Increased
57
Reduced
50
Closed
8
Calls
$319K
Puts
–
Net Calls
+$319K
Net Calls Change
-$278K

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$18.5M
2
NI
Numeric Investors
Massachusetts
+$10.7M
3
State Street
State Street
Massachusetts
+$10.7M
4
GT
Glenmede Trust
Pennsylvania
+$10.5M
5
GAM
Gotham Asset Management
New York
+$6.54M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$25.1M
2
SCA
SAC Capital Advisors
Connecticut
-$12.9M
3
KCM
Kingdon Capital Management
New York
-$7.3M
4
BA
BlackRock Advisors
Delaware
-$4.75M
5
AI
Ariel Investments
Illinois
-$2.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
RFC
26
Russell Frank Company
Washington
$6.03M +$3.64M +143,939 +152%
Morgan Stanley
27
Morgan Stanley
New York
$5.64M +$2.28M +90,279 +68%
PRCM
28
Pine River Capital Management
Minnesota
$5.46M +$5.46M +216,100 New
Wellington Management Group
29
Wellington Management Group
Massachusetts
$5.11M +$331K +13,100 +7%
Two Sigma Advisers
30
Two Sigma Advisers
New York
$5.02M +$3.15M +124,600 +169%
BIM
31
Bogle Investment Management
Massachusetts
$4.89M +$4.88M +193,383 New
Geode Capital Management
32
Geode Capital Management
Massachusetts
$4.85M +$879K +34,786 +22%
KCM
33
Kingdon Capital Management
New York
$4.72M -$7.3M -289,200 -61%
SBH
34
Segall Bryant & Hamill
Illinois
$4.68M -$12.3K -485 -0.3%
Principal Financial Group
35
Principal Financial Group
Iowa
$4.67M +$209K +8,291 +5%
PI
36
Putnam Investments
Massachusetts
$4.63M +$4.63M +183,400 New
Jacobs Levy Equity Management
37
Jacobs Levy Equity Management
New Jersey
$4.61M -$190K -7,510 -4%
CM
38
Castleark Management
Illinois
$4.55M +$4.55M +180,225 New
TCIM
39
TIAA CREF Investment Management
New York
$4.51M -$75.3K -2,980 -2%
American Century Companies
40
American Century Companies
Missouri
$4.23M +$2.61M +103,252 +161%
Acadian Asset Management
41
Acadian Asset Management
Massachusetts
$4.21M +$1.47M +58,325 +54%
Arrowstreet Capital
42
Arrowstreet Capital
Massachusetts
$3.38M +$1.84M +73,040 +120%
MOACM
43
Mutual of America Capital Management
New York
$3.37M +$144K +5,700 +4%
CRC
44
Curi RMB Capital
Illinois
$3.37M -$32.5K -1,288 -1%
GC
45
Guggenheim Capital
Illinois
$3.33M +$56.2K +2,224 +2%
SIM
46
Spark Investment Management
New York
$3.25M +$1.55M +61,500 +92%
CAM
47
ClariVest Asset Management
California
$2.97M +$2.01M +79,635 +210%
Ameriprise
48
Ameriprise
Minnesota
$2.97M +$91K +3,602 +3%
Millennium Management
49
Millennium Management
New York
$2.92M +$86.3K +3,418 +3%
Allianz Asset Management
50
Allianz Asset Management
Germany
$2.84M +$2.84M +112,536 New
1
2
3 4 5

EBS Hedge Fund Activity: Q1 2014 in Review

168 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q1 2014, worth a combined $717M — up 26% from $570M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new EBS positions and 8 closed out — a net gain of 36 holders — while 57 added to existing stakes and 50 trimmed.

The largest buyer was Broadfin Capital, adding an estimated $18.5M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $25.1M sold.

  • 168 institutional investors held Emergent Biosolutions (EBS) as of Q1 2014, up from 132 in Q4 2013.
  • Funds reported $717M of Emergent Biosolutions stock for Q1 2014, up 26% quarter-over-quarter.
  • 44 funds opened new Emergent Biosolutions positions in Q1 2014 and 8 closed out, a net change of +36 holders.
  • The largest Emergent Biosolutions buyer in Q1 2014 was Broadfin Capital, an estimated $18.5M added.
  • The largest Emergent Biosolutions seller in Q1 2014 was Consonance Capital Management, an estimated $25.1M sold.

Based on aggregated 13F filings for Q1 2014.